ROG.SW

Roche Holding AG [ROG.SW] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

ROG.SW Stock Summary

Top 10 Correlated ETFs

ROG.SW

Top 10 Correlated Stocks

ROG.SW

In the News

ROG.SW Financial details

Company Rating
-
Market Cap
181.34B
Income
23.92B
Revenue
122B
Book val./share
-
Cash/share
-
Dividend
9.5
Dividend %
3.78%
Employees
103.61K
Optionable
No
Shortable
Yes
Earnings
01 Feb 2024
P/E
16.17
Forward P/E
-
PEG
1.76
P/S
3.19
P/B
7.17
P/C
-
P/FCF
14.57
Quick Ratio
0.92
Current Ratio
1.24
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
29.81
EPS next Y
-
EPS next Q
-
EPS this Y
-7.34%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-1.81%
Revenue last 5Y
-1.63%
Revenue Q/Q
-2.83%
EPS Q/Q
-38.75%
-
-
-
-
SMA20
-13.02%
SMA50
-10.59%
SMA100
3.2%
Inst Own
-
Inst Trans
-
ROA
14%
ROE
47%
ROC
0.29%
Gross Margin
68%
Oper. Margin
28%
Profit Margin
20%
Payout
60%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
217.0-293.55
52W High
-8.09%
52W Low
+24.1%
RSI
50.4
Rel Volume
1.15
Avg Volume
1.41M
Volume
1.62M
Perf Week
5.36%
Perf Month
-13.44%
Perf Quarter
-1.39%
Perf Half Y
-3.06%
-
-
-
-
Beta
0.148
-
-
Volatility
4.95%, 23.44%
Prev Close
0.15%
Price
269.3
Change
0.82%

ROG.SW Financial Performance

ROG.SW Dividend History

ROG.SW Frequently Asked Questions

What is Roche Holding AG stock symbol ?

Roche Holding AG is a CH stock and trading under the symbol ROG.SW

What is Roche Holding AG stock quote today ?

Roche Holding AG stock price is $269.3 today.

Is Roche Holding AG stock public?

Yes, Roche Holding AG is a publicly traded company.

Something similar

Top by Market Cap
3V64.DE
ABEC.DE
MSF.DE
LLY
FB2A.DE
Top Correlated ETFs
2B70.DE
6PSK.DE
EHLT.DE
EMEC.DE
ESIH.DE
Top Correlated Stocks
RO.SW
RF.PA
RXL.PA
SHL.DE
2OY.DE
Similar Market Cap
9873.T
COWB
001130.KS
JJTB
4552.T

Company Profile

Healthcare Drug Manufacturers - General
  • Volume Average 1.41M
  • Market Capitalization 181.34B
  • Employee 103.61K
  • CEO Dr. Thomas Schinecker
  • Headquarters Basel,CH
  • IPO Date 1995-08-03
  • Website https://www.roche.com

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunology, cardiovascular and metabolism, ophthalmology, and respiratory, as well as anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune, neurological, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. The company was founded in 1896 and is headquartered in Basel, Switzerland.